Table 3 Comparing bone remodeling parameters and serum sclerostin levels among all groups (I and II and III)
From: Serum sclerostin and sympathetic skin response: relationship with myeloma bone disease
Parameter | ALP (U/l) | Vitamin D (ng/ml) | PTH (pg /ml) | Serum sclerostin (ng/ml) | ||
|---|---|---|---|---|---|---|
Group I | 20.3 (± 11.7) | 16.7 (± 10.2) | 30.2 (± 6.1) | 0.52 (± 0.38) | ||
Group II | 14.7 (± 11.7) | 19.3 (± 5.2) | 31.6 (± 2.9) | 0.77 (± 0.37) | ||
Group III | 18.3 (± 11.2) | 20.1 (± 9.2) | 31.9 (± 3.7) | 0.41 (± 0.36) | ||
P | Group I versus III | 0.47 | 0.15 | 0.16 | 0.02* | |
P | Group II vs | group I | 0.04+ | 0.18 | 0.22 | 0.03+ |
Group III | 0.19 | 0.65 | 0.71 | 0.01* | ||